Kate Cornish-Bowden was appointed a non-executive Director of the Company on 20 May 2020. Kate worked for Morgan Stanley Investment Management from 1992 to 2004 where she was a Managing Director, head of MSIM’s global core equity business and head of the pharmaceuticals research team. Prior to joining Morgan Stanley, she worked for M&G Investment Management as a research analyst. Kate is currently a non-executive director of Finsbury Growth & Income Trust plc, Schroder Oriental Income Fund Ltd and CC Japan Income & Growth Trust plc, where she is also Audit Committee Chair. She has previously held directorships at Calculus VCT plc, Scancell Holdings plc and Arcis Biotechnology Limited. Kate is a member of the Chartered Financial Analyst Institute (formerly AIIMR), holds an MBA and has completed the Financial Times Non-Executive Director Diploma.